HSPD1 and COVID-19: Among them, it is interesting to highlight the studies of Jakovac [44] on hypertension, Hernandez-Cedeño et al. [45] on hyperinflammation, Mantej et al. [46] on autoantibodies, and Saha and Ahmed [47] on coagulation cascade, as these were conducted by groups independent from ours but yielded results comparable to those obtained in our studies, particularly regarding the involvement of Hsp60 in severe forms of COVID-19 [9] and post-COVID [48], as explained in more detail below.